Home » Newsletters » BioWorld

BioWorld

April 4, 2000

View Archived Issues

CuraGen, Gemini Collaborate To Link SNPs, Clinical Data

BioChem Pharma, Government Team In $413M Vaccines Effort

Synsorb Starts Enrollment In Phase III Trial Of Diarrhea Drug

AACR Meeting

Other News To Note

Avanir Lands $25M Deal For Cold-Sore Product With SKB

MDS Spin-Off Raises $57M To Focus On Protein Interactions

Kosan, Telik Join Lineup Of Companies Proposing IPOs

Insect Sterility Ploy To Control Agricultural Pests, Mosquito- Carriers Of Human Infections

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.